previous compound ID: 1386 next compound
InChIKey: MKFFGUZYVNDHIH-UHFFFAOYSA-N
SMILES: CC(C)NCC(C1=CC(=CC(=C1)O)O)O.CC(C)NCC(C1=CC(=CC(=C1)O)O)O.OS(=O)(=O)O

biological descriptors:

CFTR relevance: unspecified

Category:
Influence on CFTR function unknown
Order of interaction unknown
subcellular compartment unknown

reference list:

ReferenceID: 53
"D Rotin" "J Goepp" "R Robert" "DY Thomas" "GW Carlile" "E Matthes" "JW Hanrahan" "SD Macknight" "B Kus" "J Liao"

chemical graph of compound 1386





CID is 441333
synonyms found at PubChem are:
5874-97-5, Metaproterenol sulfate, Orciprenaline sulfate, Metaproterenol hemisulfate salt, Metaproterenol hemisulfate, Alupent (TN), Metaproterenol sulfate, orciprenaline sulfate, EN300-50867, TH-152, DSSTox_CID_25391, DSSTox_RID_80848, DSSTox_GSID_45391, bis(5-[1-hydroxy-2-(propan-2-ylamino)ethyl]benzene-1,3-diol); sulfuric acid, 5-[1-hydroxy-2-(propan-2-ylamino)ethyl]benzene-1,3-diol;sulfuric acid, Prestwick_845, Metaproterenol sulphate, AC1L9AZJ, AC1Q7DNI, NCGC00016662-01, CAS-5874-97-5, SCHEMBL41815, Metaproterenol sulfate (USP), Orciprenaline sulfate (JP17), CHEMBL1568057, DTXSID4045391, CTK8A7112, MolPort-003-921-112, HMS1569F11, HMS2096F11, HMS3262C10, HMS3713F11, Tox21_110551, Tox21_500734, MFCD00058303, AKOS015994757, Tox21_110551_1, CCG-220505, CCG-222038, LP00734, MCULE-1763503293, SS-4263, NCGC00015655-09, NCGC00094078-01, NCGC00261419-01, CC-30246, O694, EU-0100734, FT-0628263, D00685, M 2398, 874M975, SR-01000872665, SR-01000872665-1, Z955123630, 5-(1-hydroxy-2-(isopropylamino)ethyl)benzene-1,3-diol hemisulfate, bis(5-(1-hydroxy-2-(isopropylamino)ethyl)benzene-1,3-diol) sulfate, 5-[1-hydroxy-2-(propan-2-ylamino)ethyl]benzene-1,3-diol; sulfuric acid, Metaproterenol sulfate, United States Pharmacopeia (USP) Reference Standard, Orciprenaline sulfate, European Pharmacopoeia (EP) Reference Standard, bis(5-{1-hydroxy-2-[(propan-2-yl)amino]ethyl}benzene-1,3-diol); sulfuric acid, Orciprenaline for system suitability, European Pharmacopoeia (EP) Reference Standard, Novasmasol, Orciprenaline sulphate, EINECS 227-539-6, 1-(3,5-Dihydroxyphenyl)-2-(isopropylamino)ethanol sulfate, 1-(3,5-Dihydroxyphenyl)-1-hydroxy-2-isopropylaminoethane sulfate, 3,5-Dihydroxy-alpha-((isopropylamino)methyl)benzyl alcohol sulfate, 3,5-Dihydroxy-alpha-((isopropylamino)methyl)benzyl alcohol sulfate (2:1), (+-)-3,5-Dihydroxy-alpha-((isopropylamino)methyl)benzyl alcohol sulfate (2:1), 1,3-Benzenediol, 5-(1-hydroxy-2-((1-methylethyl)amino)ethyl)-, sulfate (2:1) (salt), 1,3-Benzenediol, 5-(1-hydroxy-2-((1-methylethyl)amino)ethyl)-, sulfate (2:1) salt, 1,3-Benzenediol, 5-(1-hydroxy-2-(1-methylethyl)amino)ethyl-, (+-)-, sulfate (2:1) (salt), Benzyl alcohol, 3,5-dihydroxy-alpha-((isopropylamino)methyl)-, sulfate (2:1) (salt), Metaproterenol sulfate [USAN], Metaproterenol sulfate [USAN:USP], LS-42875